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The term "probiotic" or direct-fed microbial (DFM) was originally defined by 
Roy Fuller as "a live microbial feed supplement which beneficially affects the host 
animal by improving its microbial balance" (Fuller 1992).  Since then, Guarner and 
Schaafsma have expanded that definition to "living microorganisms which, upon 
ingestion in certain numbers, exert health benefits beyond inherent general 
nutrition" (1998).  Probiotic therapy has been recommended for the treatment or 
prevention of a variety of conditions in different species.  The advantages of 
probiotic consumption in humans have been recognized for centuries.  However, 
their application and efficacy in domestic animals have only recently been pursued. 
 Properties of probiotics that one may find appealing include the ability to 
reduce antibiotic use and the positive perception about natural or alternative 
therapies.  While antibiotic therapy is effective at reducing or eliminating 
pathogenic microorganisms, it is equally as effective at eliminating the host's gut 
microflora, upsetting the natural microbial balance essential to a functional 
gastrointestinal tract and immune system.  By introducing probiotics into the 
gastrointestinal tract of  humans and animals, many health benefits can be seen such 
as improved nutritional value of food, control of intestinal infections, 
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 improvement of lactose utilization, control of some types of cancer, and control of 
serum cholesterol levels (Gilliland 1990).   
 A potential probiotic strain is expected to have the following desirable 
properties.  The species-specific microorganism should be a normal inhabitant of 
the gastrointestinal tract of healthy hosts (Biourge and others 1998; Dunne and 
others 1999).   To elicit health-promoting effects, the bacteria must survive the 
harsh environment of the gastrointestinal tract.  The stomach's natural defense 
against microorganisms is the gastric acid having an extremely low pH (Suscovic 
and others 1997).  The mean intestinal bile acids concentration in the human 
gastrointestinal tract is about 0.3% w/v (Gilliland and others 1984).  Therefore, bile 
tolerance is important if the microorganism is expected to grow in the 
gastrointestinal tract.  Finally, adhesion to the intestinal mucosa is considered a 
prerequisite for successful colonization and is important for immune modulation 
(Ouwehand and others 1999). 
 A number of direct-fed microbials are available commercially for use in dogs, 
mainly in the form of capsules, tablets, pastes, and liquid. However, none of these 
products are of canine origin.  In addition, many of these products contain 
Enterococcus faecium (Benyacoub and others 2003; Rinkinen and others 2003) and 
therefore, raise questions of safety due to antibiotic resistance genes and the 
bacterium’s pathogenic nature (Rinkinen and other 2003; Franz and others 1999).  
The addition of probiotics into diets may have the advantage of easy, daily 
administration.  Therefore, the aim of this study was to determine the effects of a 
potential probiotic, Lactobacillus reuteri X-18, on several biochemical and 
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immunological parameters in healthy beagles.  Twenty beagle puppies were used in 
this feeding trial.  Of the twenty, ten were fed an experimental diet of 10% non-fat 
dry milk containing the probiotic while the remaining ten were fed a control diet of 
10 % non-fat dry milk without the probiotic.  Positive effects on biochemical and 
immunological parameters by the direct-fed microbial would indicate the culture 





REVIEW OF LITERATURE 
 
LACTIC ACID BACTERIA (LAB) 
 Fermentation as a food preservation method can be traced back thousands of 
years.  It is only in the more recent past that microorganisms were found to be 
responsible for the fermentation process.  Due to the industrial revolution, there 
was a shift from small-scale production to large-scale production of fermented foods 
and alcoholic beverages.  The use of starter cultures, primarily lactic acid bacteria 
(LAB), contributed to extending shelf-life and quality of the food product.  The 
group, lactic acid bacteria, is composed of a number of genera including Lactococcus, 
Lactobacillus, Enterococcus, Streptococcus, Leuconostoc, and Pediococcus.  These 
bacteria generally produce lactic acid as their major end product.  Lactic acid 
bacteria lack a terminal electron transport chain, therefore are strictly fermentative, 
and are catalase negative (Condon 1987).  Lactic acid bacteria can be subdivided 
into two groups based on carbohydrate metabolism.  Homofermentative LAB use 
the Embden-Meyerhof-Parnas (EMP) pathway to convert 1 mole of glucose into 2 
moles of lactate.  Heterofermentative bacteria use the hexose monophosphate or 
pentose pathway to  produce equal molar amounts of 
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lactate, CO2, and ethanol from glucose.  Many organic acids such as lactic, acetic, and 
propionic acids produced as end products of fermentation provide an environment 
unfavorable for the growth of many pathogenic and spoilage microorganisms.  Such 
acids interfere with the cell membrane potential, inhibit active transport, reduce 
intracellular pH, and inhibit various metabolic functions (Doores 1993) and can 
inhibit both Gram-positive and Gram-negative bacteria and yeasts and molds (Blom 
and Mortvedt 1991).  Antimicrobial metabolites such ethanol and hydrogen 
peroxide can have oxidizing effects on membrane lipids and cellular proteins (Ray 
and Daeschel 1992; Condon 1987).  Another example of an antimicrobial secondary 
metabolite produced is the compound reuterin, by the LAB, Lactobacillus reuteri.  
Reuterin consists of monomeric, hydrated monomeric, and cyclic dimeric forms of 
β-hydroxypropionaldehyde.  It is considered to have broad spectrum activity that 
inhibits the growth of protozoa, fungi, and various Gram-positive and Gram-
negative bacteria (Axelsson and other 1989; Chung and others 1989; Talarico and 
Dobrogosz 1989).   
Almost all of the different species of LAB have been reported to produce 
antimicrobial compounds collectively called bacteriocins.  Bacteriocins are 
proteinaceous substances which can inhibit or reduce undesirable microflora in 
food products (Klaenhammer 1988; Holzapfel and others 1995) by depolarizing 







            In the early 1900's, Metchnikoff proposed that the lactic acid bacteria were 
antagonistic to the spoilage microbes of the gut and, once introduced into the 
gastrointestinal tract, would prevent the growth of harmful microorganisms that 
required an alkaline environment (1921).  By experimenting on himself, he noted 
his poor health improving by the regular ingestion of a sour milk prepared by 
cultures of lactic acid-producing bacteria.  This discovery led to physicians 
recommending the use of such products as yogurt or sour milk to those who were 
generally regarded as suffering from poor health.  Crediting his relative long life in 
part to the lactic bacilli, he hypothesized that "once people learned how to cultivate 
a suitable flora in the intestines of children as soon as they are weaned from the 
breast, the normal life may extend to twice my 70 years" (Metchnikoff 1921).  
Studies since then have shown health benefits ranging from improved lactose 
utilization in those otherwise considered lactose intolerant to increased immune 
response in an individual.  In 1998, Guarner and Schaafsma expanded Fuller's 
traditional definition of a probiotic or direct-fed microbial (DFM) to "living 
microorganisms which, upon ingestion in certain numbers, exert health benefits 
beyond inherent general nutrition" (Guraner and Schaafsma 1998). 
In a study done by DeSimone and others, results showed that ingesting 
yogurt may enhance the immune response by increasing the percentage of B 
lymphocytes, phytohemagglutamin (PHA), and lipopolysaccharide(LPS)-induced 
proliferative responses of Peyer's patches in the intestine (1987).  In 1999, Van de 
Water and others noted a decreased incidence of allergies in the live-active yogurt 
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group compared with the heat-killed and no-yogurt groups.  The mechanisms by 
which probiotics stimulate the immune system have not all been elucidated but 
studies have been done that have allowed us to better understand the immune 
response. 




Selection criteria for potential probiotic cultures consist of: 1) acid and bile 
tolerance, 2) persistence in the gut even if it cannot colonize the gut, 3) ability to 
adhere to the gut epithelium to withstand the flushing effects of peristalsis, 4) ability 
to interact or send signals to the immune cells associated with the gut, 5) species-
specificity, 6) generally recognized as safe (GRAS), 7) having the capacity to 
influence local metabolic activity, and 8) withstanding processing conditions 
Lactobacillus  sps. Bifidobacterium  sps Streptococcus  sps.
L. acidophilus B. bifidum S. thermophilus
L. casei (rhamnosus) B. breve S. salivarius ssp thermophilus
L. fermentum B. lactis
L. gasseri B. longum
L. johnsonii B. infantis






Table 1.  Species of bacteria used as probiotics
1,2
1
Givson and Roberfroid 1995.
2
Alvarez-Olmos and Oberhelman 2001.
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(Harmsen and others 2000).  The claimed benefits of probiotics include improved 
nutritional value of food, increased absorption of calcium (Hamilton-Miller 2004), 
lowered activity of β-glucuronidase, β-glycosidase, azoreductase, and nitroreductase 
which are known to convert pre-carcinogens to carcinogens (Burns and Rowland 
2000), control of intestinal infections, improvement of lactose utilization in persons 
labeled as lactose intolerant,  and control of serum cholesterol levels (Gilliland 
1990).  In humans, the dose of 5 x 109 CFU/day for at least five days is 
recommended to obtain an adequate amount of health benefits conferred by the 
probiotic (Gronlund and others 1999).  Factors such as antagonism and competition 
help regulate the composition of the microflora as well as help to suppress the 
establishment of pathogenic bacteria in the intestinal tract (Tannock and 
Archibald1984).  This process involves cooperation between the intestinal 
microflora and the immune system of the host (Tannock and Savage 1976).  Immune 
effects can be influenced by the intestinal microflora, since the antigenic load 
provided by the intestinal microbes serves to stimulate the immune system (Gordon 
and Pesti 1971).   
 
LACTOBACILLUS REUTERI 
 Among the numerous species of Lactobacillus found in the gastrointestinal 
tract of humans, pigs, chickens, and other animals, Lactobacillus reuteri is 
considered a prominent member of the gastrointestinal complex (Kandler and 
others 1980).  Little is known about L. reuteri and less about reuterin, a newly 
discovered broad-spectrum antimicrobial substance produced by this species 
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(Talarico and others 1988).  Studies have indicated that reuterin or 3-
hydroxyproprionaldehyde (3-HPA) is a low molecular weight, neutral, water-
soluble, non-protein substance, produced specifically from glycerol fermentation by 
anaerobic resting cells, that has anti-bacterial, anti-mycotic, and anti-protozoal 
activity (Luthi-Peng and others 2002).  It has been shown that reuterin is an 
intermediary metabolite by which glycerol is first dehydrated to form reuterin, 
some of which is then reduced to 1,3-propanediol (Chung and others 1989; Axelsson 
and others 1989).  Compositionally, reuterin is an equal mixture of monomeric, 
hydrated monomeric and cyclic dimeric forms of 3-HPA (Talarico and Dobrogosz 
1989). 
 
GASTROINTESTINAL IMMUNE SYSTEM 
 The intestinal tract is the largest mass of lymphoid tissue and is generally 
referred to as the gut-associated lymphoid tissue (GALT).  This is the location where 
ingested bacteria first make contact with the host's mucosal immune system 
(Brandtzaeg and others 1989).  Structural and functional components of the 
gastrointestinal tract are part of the mechanisms that provide protection from 
potential pathogens and excessive antigenic exposure.  Such structural components 
consist of the epithelial tight junctions, the microvillus membrane, and a surface 
mucous layer.  Examples of functional components include peristalsis, gastric acid, 
and proteolytic enzymes (Guilford and Strombeck 1996).  Beneath the mucosal 
epithelium is the lamina propria.  Within the lamina propria is the GALT.  Gut-
associated lymphoid tissue can be found along the entire length of the 
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gastrointestinal tract and is composed of Peyer's patches.  The most immune activity 
occurs within the GALT (Ettinger and Feldman 2005).  A single unit of GALT consists 
of the dome, follicle, and parafollicular region.  The dome is comprised of specialized 
enterocytes, called M cells, that act as antigen-presenting cells (APC).  Example of 
APC's are macrophages or dendritic cells.  The follicle contains B lymphocytes while 
the parafollicular region contains mostly naive T lymphocytes (Banks 1992).  
Antigens are presented to lymphocytes by APC's.  The lymphocytes becomes 
activated after receiving activation signals from APC's and helper T cells.  These 
activated lymphocytes move through mesenteric lymph nodes into circulation and 
return to the lamina propria.  T cells promote tolerance to food antigens and normal 
gastrointestinal microflora and play a key role in the development of intestinal 
inflammation.  Therefore, treatments often target modulating T cells.  B 
lymphocytes produce plasma cells.  Plasma cells aggregate in the lamina propria and 
mainly produce immunoglobulin A (IgA).  IgA bind antigens on mucosal surfaces 
such as the gastrointestinal epithelium, and are more resistant to proteolytic 
enzymes produced by enteric microflora than other types of immunoglobulins 
(Janeway and others 2005).  The role of IgA is very important in gastrointestinal 
immune reponses.  Secretory IgA is formed when a part of the immunoglobulin (Ig) 
receptor remains bound to the dimeric IgA, following transport of IgA across the 
epithelial barrier (Sampson 1991).  Secretory IgA inhibits the attachment and 
penetration of bacteria and toxins in the lumen, increases time for digestive 
enzymes to function, binds and prevents absorption of undigested protein, increases 
mucous secretion and prevents inflammatory reactions (Russell and others 1989; 
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McKay and Perdue 1993).  Secretory immunoglobulin A (IgA) plays an important 
role in mucosal immunity, acting as an added barrier against pathogenic bacteria.  
Probiotic bacteria increase the number of IgA-producing cells (Szajewska and others 
2001) and certain cytokines that up or down regulate the immune responses 
(Arvola and others 1999).  Unfortunately, interactions between probiotic 
microorganisms and GALT, mechanisms of immunomodulation and anti-
inflammatory properties are not fully understood.   
 Recent research interests have focused on the effect of LAB on specific and 
non-specific immune functions.  Strains of LAB have been found to secrete 
lysosomal enzymes and enhance phagocytosis (Gill 1998).  Probiotic bacteria have 
been shown to enhance humoral immune responses, promoting the intestine's 
immunologic barrier (Isolauri  and others 1993; Kaila and others 1992).  Probiotics 
can also stimulate non-specific host resistance to microbial pathogens (Perdigon 
and others 1986) and  modulate the host's immune responses to potentially harmful 
antigens (Sutas and others 1996a,b). 
 Stimulation of non-specific immunity can be observed by the release of the 
proinflammatory cytokines tumor necrosis factor α, interleukin-6 (IL-6), and 
interleukin-10 (IL-10) (Miettinen and others 1996).   Probiotics can activate the 
production of macrophages (Perdigon and others 1986) and phagocytosis (Perdigon 
and others 1998).  Phagocytosis is responsible for early activation of the 
inflammatory response before antibody production, the recruitment of 
immunocompetent cells, and the generation of the inflammatory response (Isolauri 
and others 1997).  In healthy subjects, modulation of phaygocytosis resulted in an 
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immunostimulatory effect, while in subjects suffering from food allergies, down-
regulation of the inflammatory response was observed (Pelto and others 1998).  
Since intestinal inflammation is accompanied with an imbalance in the gut 
microflora, probiotics may help stabilize the gut microflora (Salminen and others 
1998) and prevent the production of inflammatory mediators (Brandtzaeg 1995). 
 Certain species of bacteria isolated from the gastrointestinal tract can 
produce low-molecular weight peptides that trigger immune responses.  Proteases 
utilized by probiotics can degrade the milk protein casein generating peptides that 
suppress the proliferation of lymphocytes (Sutas and others 1996b). 
 
DOGS AS COMPANION ANIMALS  
 For decades, dogs (Canis familiaris) have been used to aid humans in tasks 
such as hunting, herding and guarding. Dogs have also been used to enhance the 
quality of life of individuals with disabilities. However, as society has moved from 
small rural communities to increasingly large urban and suburban centers, the role 
of dogs as companions has increased (Table 2).  Dogs decrease loneliness and 
provide opportunities for exercise and social interactions with other people. 
Furthermore, medical research has shown that contact with dogs can decrease 
feelings of anxiety and stress, and lower blood pressure in humans (Friedmann and 
others 1983). Since dogs live 10 to 20 years, people must be ready to provide them a 







Table 2. U.S. Pet Ownership and Demograhics. 
  
 Dogs Cats Birds Horses 
Percent of households owning 37.2% 32.4% 3.9% 1.8% 
Number of households owning 43,021,000 37,460,000 4,453,000 2,087,000 
Average number owned per 
household 
1.7 2.2 2.5 3.5 
Total number in United States 72,114,000 81,721,000 11,199,000 7,295,000 
Veterinary visits per household per 
year (mean) 
2.6 1.7 0.3 2.2 
Veterinary expenditure per 
household per year (mean) 
$356 $190 $25 $360 
Veterinary expenditure per animal 
(mean) 
$200 $81 $9 $92 
(American Veterinary Medical Association.  2007) 
 
 
GASTROINTESTINAL MICROFLORA OF DOGS 
              Knowledge of the structure of the bacterial community in the gastrointestinal 
tract of the dog is essential to understand the interactive processes and the impact 
on the health status of the animal.  The gut microflora of dogs consists of over four 
hundred various bacterial species with members of the genus Bifidobacterium 
making up the dominant microflora (Chien-Chang and Walker 2005).  Traditionally, 
cultural and phenotypic approaches have been taken to quantify predominant fecal 
microflora of the canine gut.  Previous studies have presumptively identified 
lactobacilli and bifidobacteria isolated from dog feces by Gram reaction and gas 
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liquid chromatography analyses of metabolic end products (Hartemink and 
Rombouts 1999; Martineau 1999).  The use of molecular-based methods in 
combination with traditional methods will allow more accurate analyses of the 
diversity of the gastrointestinal tract (Drancourt and others 2000).  More work must 
be directed on the derivation and testing of probiotics for dogs.  Benno and others 
concluded that microbial populations in the canine gut change with time suggesting 
that bacterial populations may vary independently from the diet (1992).  No 
detectable differences in gut microflora of the stomach, duodenum, jejunum and 
ilieum were seen but in the large bowel, differences in microbial populations were 
observed.  Larger populations of lactobacilli were seen in the large bowel but 
decrease with age (Benno and others 1992).  The large amount of the bacterial 
diversity remains undetermined emphasizing the need to develop more efficient 
recovery and identification procedures to determine future probiotic and prebiotic 
products. 
 
PROBIOTICS FOR DOGS 
 Lactic acid bacteria (LAB) constitute a major group of bacteria to be used as 
probiotics for animals (Biourge and others 1998).  The criteria that must be met for 
a given microorganism to be termed probiotic are the same for dogs as they are for 
humans.  Strains of Lactobacillus and Bifidobacterium are most frequently used as 
probiotics in humans and large animals.  Species of Lactobacillus are Gram-positive, 
non-spore forming, facultative anaerobic rods.  They are capable of rapidly 
colonizing the intestinal epithelium and inhibiting the growth of enteric pathogens.  
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In addition, their immunomodulatory functions increase the activity of macrophages 
and the concentration levels of immunoglobulins (Chrzastowska and others 2009).  
Classical traits for the evaluation of probiotics such as higher feed conversion and 
weight gain are not relevant for companion animals (Lahrssen and Zentek 2002).  
However, modification of the immune function in dogs (Benyacoub and others 
2003; Baillon and other 2004) and the composition and metabolic activity of canine 
intestinal microflora (Rinkinen and others 2000; Weese and Anderson 2002; Rastall 
2004) are key characteristics of probiotics that are useful in determining their 
potential use in dogs.  Unlike the effects of probiotics seen in dogs suffering from 
gastrointestinal conditions, modifications in the intestinal microbiology are not 
necessarily accompanied by obvious clinical benefits in healthy dogs.  Lactobacillus 
acidophilus DSM 13241 has been found to survive the incorporation into dry dog 
food and transiently colonizes the colon of dogs (Baillon and others 2004).  The 
desired outcome would be that it reduces or at least antagonizes undesirable, 
potentially harmful, or pathogenic microorganisms.  It was observed that fecal 
concentrations of lactobacilli and bifidobacteria increased, while not significantly, 
during supplementation, indicating a small shift in the composition of the intestinal 
microflora.  Research on probiotics for dogs has focused mainly on alleviating 
lactose intolerance in dogs.  Lactose intolerance can be defined as the inability to 
metabolize lactose.  Probiotics can convert lactose to lactic acid, enhancing lactose 
fermentation, thus alleviating symptoms of  lactose intolerance (Lewis and 
Freedman 1998; Sullivan and Nord 2005).  Probiotic bacteria have been proven 
effective in the treatment of small intestinal bacterial overgrowth (SIBO) in dogs.  
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SIBO  is characterized by an uncontrolled increase in microbial populations in the 
small intestine (Lewis and Freedman 1998).  This results in the alteration in the 
composition of intestinal microflora causing the accumulation of E. coli, Salmonella, 
Campylobacter or Clostridium, causing luminal fluid loss and subsequently leading to 
diarrhea (Delles and other 1994; Rutgers and others 1995).  It has also been shown 
that probiotics can alleviate SIBO through competitive inhibition and by the 
production of bacteriocins such as reuterin (Marteau and others 2001; Barefoot and 
Nettles 1993).  The addition of probiotics to dog food is thought to promote overall 
health over the dog's lifespan and particularly the development of its immune 
system (Benyacoub and others 2003; Biourge and others 1998).  Clinical indications 
for using probiotics in dogs are not well defined and have been adapted from 
concepts developed for humans.  However, the treatment and prevention of 
common digestive disorders and unfavorable changes in the gastrointestinal 
microflora is a relevant application for the use of probiotics in dogs.  In 2007, McCoy 
and Gilliland published a study in which they isolated and characterized species of 
Lactobacillus having potential for use as probiotics for dogs.  Based on their results, 
Lactobacillus reuteri was the predominant species isolated from dogs and the best 
prospective culture (X-27 and X-18) to use for potential probiotics for dogs based on 
bile tolerance, inhibitory action,  and the production of reuterin. 
 
IMMUNOMODULATORY EFFECTS OF PROBIOTICS  
        The role of immunoglobulin A (IgA) is very important in gastrointestinal 
immune reponses.  Secretory IgA is formed when a part of the immunoglobulin (Ig) 
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receptor remains bound to the dimeric IgA, following transport of IgA across the 
epithelial barrier (Sampson 1991).  Secretory IgA inhibits the attachment and 
penetration of bacteria and toxins in the lumen, increases time for digestive 
enzymes to function, binds and prevents absorption of undigested protein, increases 
mucous secretion and prevents inflammatory reactions (Russell and others 1989; 
McKay and Perdue 1993). 
          Four classes of immunoglobulins have been identified and characterized in 
dogs and appear to be similar to those of other species.  The measurement of serum 
immunoglobulin concentrations is one of the most commonly used methods of 
assessing the immune competence in dogs.  Dogs having IgA deficiency may suffer 
from diseases such as inflammatory bowel disease (IBD) or small intestinal bacterial 
overgrowth (SIBO) (Batt and others 1991).  Past studies have utilized single radial 
immunodiffusion (SRID) to quantify canine immunoglobulins.  However, the 
sensitivity of enzyme-linked immunosorbent assay (ELISA) renders this method 
more desirable (Ginel and others 1996).  Findings from a study done by German and 
others (1998) show large variation in the concentrations of secreted 
immunoglobulins within individual dogs.   
 
COMPLETE BLOOD COUNT 
 A complete blood count, commonly referred to as a CBC, is a count of the 
total number of cells in a given amount of blood.  A second type of test is a blood 
chemistry panel, which measures the quantities of various electrolytes, enzymes, or 
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chemical compounds in the liquid portion of a blood sample.  The CBC is concerned 
with the quantities and types of red blood cells, white blood cells, and platelets. 
Red Blood Cells 
 Red blood cells (RBCs) are responsible for carrying oxygen throughout the 
body.  Oxygen taken into the body attaches to the hemoglobin contained in the RBCs 
and taken to the lungs.   The RBCs then deliver oxygen to the body and take the 
carbon dioxide back to the lungs.  Red blood cells are formed in the bone marrow 
which constantly produce new RBCs, since the life span of an RBC is only about 120 
days (NIH 1993).   
There are several different ways one can determine the number of RBCs in 
the CBC.  The quickest and easiest method is called the hematocrit, also referred to 
as the packed cell volume (PCV).  A blood sample is centrifuged to allow heavier 
cells to collect allowing the PCV to be determined as the percentage of the cellular 
portion relative to the total amount of blood (the plasma)(Willard and Tvedten 
2004).  Anything that decreases the amount of oxygen reaching tissues in the body 
will cause higher numbers of RBCs in the CBC.  Another method of determining the 
number of RBCs in the CBC is by the Red Blood Cell Count or “red count”.  An actual 
number of RBCs is counted in one microliter of blood.  A final method to determine 
RBCs is by quantifying the amount of hemoglobin present (Willard and Tvedten 
2004).  Other indices of red blood cells include Mean Corpuscular Volume (MCV), 
which is the average volume of the red cells, Mean Corpuscular hemoglobin (MCH), 
the average amount of hemoglobin per red blood cell, and Mean Corpuscular 
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Hemoglobin Concentration (MCHC), which is the average concentration of 
hemoglobin in the cells (NIH 1993). 
White Blood Cells 
 White blood cells (WBCs), also called leukocytes, are the other major type of 
blood cells.  For every leukocyte, there are normally 600-700 RBCs.  The role of 
WBCs is to defend the body against invading microorganisms.  Elevated WBCs is 
typically indicative of infection or stress by metabolic toxins.  White blood cells are 
divided into two groups depending on how they react to the stains that are used to 
observe them under a microscope.  There are granulocytes which include 
neutrophils, eosinophils, and basophils and agranulocytes which include 
lymphocytes and monocytes (NIH 1993).   
 
Neutrophils 
 Neutrophils are formed in the bone marrow.  Segmented cells or segs are 
mature cells that have a multi-lobed nucleus while immature cells have a single-
lobed nucleus and are called bands.  Neutrophils engulf disease-causing 
microorganism.  Elevated numbers of neutrophils is usually a sign of bacterial 
infection or extreme stress (Willard and Tvedten 2004). 
 
Eosinophils 
 Eosinophils are also formed in the bone marrow.  These cells can engulf 
foreign particles.  Levels of eosinophils may be elevated due infection with parasites, 




 Basophils are formed in the bone marrow but are the least common of the 
WBCs and usually not present in samples.  Their function is unknown. 
 
Lymphocytes 
 Lymphocytes are the most abundant of the agranulocytes.  They are formed 
and released from lymphoid tissue such as lymph nodes and spleen.  There are two 
major types of lymphocytes, B cells and T cells.  B cells produce antibodies.  T cells 
activate and help other cells destroy foreign invaders (Willard and Tvedten 2004). 
 
Monocytes 
 Monocytes develop and are stored in the spleen and bone marrow and have 
the ability to engulf foreign invaders.  In addition, they have the ability to secrete 
protein molecules that help clean up inflamed tissue (Willard and Tvedten 2004). 
PLATELETS 
 Platelets are responsible for the formation of clots.  Platelets and the protein, 
fibrinogen, repair damaged blood vessels (NIH 1993). 
 
BLOOD CHEMISTRY PANEL 
 The blood chemistry panel or biochemical profile includes tests for multiple 
chemical constituents within a blood sample.  Most chemistry panels check blood 
electrolytes and for diseases of the liver, kidney, and pancreas.   While the CBC deals 
with the cell portion of blood, the chemistry panel deals with the liquid (serum) 
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portion of blood after the cells have been removed.  A typical chemistry panel will 
measure the following: 
• Blood Glucose 
• Blood Urea Nitrogen (BUN) 
• Creatinine 
• Calcium 
• Total Protein 
• Albumin 
• Globulin 
• Total Bilirubin 
• Alkaline Phosphatase 
• Alanine Amino Transferase (ALT) 
• Cholesterol 
• Sodium  
• Potassium. 
• Aspartate Aminotransferase (AST) 










 Carbohydrates ingested are converted to glycogen and stored in the liver.  
When energy is needed, the glycogen is converted to glucose.  Blood glucose can 
then be used to monitor the animal’s metabolism and physiology (Loeb 1999). 
Blood Urea Nitrogen 
 Proteins ingested are broken down by the body.  The by-product of 
metabolism is nitrogen-containing urea compounds.  Since these compounds are of 
no use to the body, they are excreted by the kidneys.  If the kidneys are not 
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functioning properly, excessively high levels of those compounds accumulate and 
are not removed from the body (Feldman and others 1982). 
 
Creatinine 
  The kidneys excrete creatinine.  If creatinine accumulates, it is indicative of 
decreased filtration rate of the kidneys (Loeb 1999). 
Calcium 
 Calcium is a mineral that is found fairly consistently within the bloodstream.  
It is linked to osseous and muscle tissues, and as an enzyme activator in all tissues.  
Lowered calcium levels can lead to serious heart and muscle disorders (Loeb 1999). 
Total Protein 
 Total protein is a measurement of both albumin and globulin.  Albumin is 
produced in the liver while globulins are produced by the body’s immune system.  
Elevated protein level is usually a sign of dehydration. 
Bilirubin 
 Bilirubin is the by-product of the breakdown of hemoglobin.  When blood 
cells die or are destroyed, hemoglobin is released and quickly broken down and 
excreted by the liver as bilirubin (Loeb 1999). 
Alkaline Phosphatase 
 Alkaline phosphatase is an enzyme that functions to assist chemical 
reactions, specifically to hydrolyze a wide range of monophosphates at an alkaline 
pH.  In dogs, higher levels of this enzyme may be seen in certain forms of cancer and 




 Alanine aminotransferase (ALT) is an enzyme important in liver function.  It 
catabolyzes amino acids and is involved in inter-organ nitrogen transport.  Elevated 
ALT usually indicates that liver cells are breaking down for some reason and that 
waste products and toxins, it normally filters from the blood, cannot be removed via 
the bile duct (Loeb 1999). 
Cholesterol 
 Cholesterol is synthesized de novo from acetate by the liver.  Before 
excretion, cholesterol is esterified in the liver.  Unlike the connotation seen in 
humans, cholesterol fluctuations in dogs are generally secondary signs of other 
diseases.  Inadequately functioning thyroid glands often cause elevated cholesterol 
levels while animals with poor nourishment may have lower cholesterol (Loeb 
1999). 
Potassium 
 Potassium is the main intracellular cation.  Intracellularly, it regulates 
osmotic pressure.  In plasma, it influences acid-base relationships.  With sodium, it 
maintains membrane potentials (Lodish and others 1995). 
Sodium 
 Sodium and potassium levels are usually compared concurrently.  Diseases of 
the adrenal glands, heart, and kidneys can severely affect their levels resulting in 
secondary problems such as preventing the heart, nerves, and kidneys from 




Aspartate Aminotransferase (AST) is an enzyme similar to ALT in that it is 
associated with liver function.  It is involved in amino acid synthesis and 
degradation, gluconeogenesis, and serves as a link between the urea and TCA cycles 
(Loeb 1999). 
Gamma Glutamyltranspeptidase 
Gamma Glutamyl Transpeptidase (GGT) is a liver enzyme that is involved in 
the transfer of amino acids across the cellular membrane and the regulation of 
intracellular growth stimulating hormone (GSH) (Loeb 1999). 
Phosphorous 
 Along with forming the structure of DNA and RNA, cells also use 
phosphorous to transport cellular energy in the form of adenosine triphosphate 
(ATP) (Loeb 1999). 
Amylase 
Amylase is an enzyme, made by the pancreas, that breaks down starch into 
sugar.  Elevated levels of amylase may be caused by acute pacreatitis (Loeb 1999). 
Lipase 
Lipase has the important functions in digestion, transportation, and 
processing of dietary lipids.  It catalyzes the transfer of fatty acids to peripheral cells 
leading to the release of glycerol into circulation (Olivecrona and Bengtsson-
Olivecrona 1993). 
Chloride 
 Chloride is an electrolyte that is necessary for metabolism and helps 
maintain an acid-base balance in the body.  The amount of chloride in the blood is 
25 
 
closely regulated by the kidneys.  It exists in combination with sodium and functions 
in the maintenance of osmotic pressure (Loeb 1999). 
Creatine Phosphokinase 
Creatine Phosphokinase (CPK) is an enzyme associated with acute renal 
injury.  It catalyzes the exchange of a phosphate moiety between creatine phosphate 
and ATP (Loeb 1999). 
 Triglycerides 
Triglycerides are energy sources for metabolism and transporters of dietary 
fat.  They aid in the hydrolysis of phospholipids from lipoproteins, specifically HDL 
(Olivecrona and Bengtsson-Olivecrona 1993). 
Magnesium 
Magnesium is an important enzyme activator.  It regulates functions similarly 
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 Lactobacillus reuteri is a probiotic culture that has been shown to increase 
the overall general well-being of animals and humans (Gilliland 1990) as well as 
help prevent infections of the gastrointestinal tract.  For successful use as a 
probiotic in dogs, the bacterial species should be of canine intestinal origin since 
these species exhibit host specificity.  In a previous study done in our laboratory 
(McCoy and Gilliland 2007), lactobacilli were isolated from dogs and characterized 
for potential use as a probiotic for dogs.  The majority of isolates were identified as 
L. reuteri.  Of these isolates, L. reuteri X-18, which was one of the most bile resistant 
strains, appeared to be the best prospective probiotic that could be used to 
supplement dog food.   
 The main objective of the present study was to evaluate the effects of feeding 
L. reuteri on various immune parameters in two-month old beagle puppies. Twenty 
beagle puppies were assigned to one of two treatments.  Ten puppies received the 
probiotic L. reuteri X-18  in ~5-10 mL of 10%  nonfat dry milk (1.0 x 109 CFU each) 
while the control group received only 10% nonfat dry milk.  Treatments were fed 
twice daily in addition to dry dog food for eight weeks.  At the end of each week, 
blood and fecal samples were collected and body weights were measured in order to 
adjust dry food rations for performance measures.  Serum and fecal 
immunoglobulin (IgA, IgE, IgM and IgG) levels, complete blood counts, and 
biochemistry panels were monitored on a weekly basis over the period of two 
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months.  All data collected was analyzed using repeated measures ANOVA.  A p-
value <0.05 was considered significant.  The immunological results of the 
experiment showed a trend of higher levels of serum IgA and IgM for the treatment 
group, although differences were not significant.  There were week effects (P<0.05) 
for serum IgA and IgG.  Three blood chemistry analytes had significant treatment x 
week interactions:  Alkaline Phosphatase (P=0.0243), Albumin (P=0.0060), and 





 The emphasis of past research on the use of probiotics for dogs has been 
mainly on alleviating lactose intolerance in dogs (Lewis and Freedman 1998).  More 
recently, probiotic bacteria have been proven effective in the treatment of small 
intestinal bacterial overgrowth (SIBO) in dogs.  This condition is described as an 
uncontrollable increase in gut bacterial population that results in the disruption of 
the intestinal microflora, causing the accumulation of Escherichia coli, Salmonella, 
Campylobacter, or Clostridium in the gut (Lewis and Freedman 1998).  This 
ultimately leads to diarrhea and the shedding of potential pathogens into the 
animal’s surroundings (Rutgers and others 1995).  The addition of probiotics into 
dog food is thought to promote overall health over a dog’s lifespan, particularly, the 
development of its immune system (Biourge and others 1998).  A number of 
probiotic supplements are available commercially for use in dogs.  However, none of 
those products are of canine origin.  McCoy and Gilliland isolated and characterized 
species of Lactobacillus having potential for use as probiotics for dogs.  Their results 
indicated that Lactobacillus reuteri was the predominant species isolated from dogs 
and the prospective species to use for potential probiotics based on bile tolerance, 
inhibitory action, and the production of the antimicrobial substance reuterin (2007).  
While the classical means of evaluating the efficacy of probiotics has been to look at 
feed conversion rates and weight gain, these traits are not relevant for companion 
animals.  However, the treatment and prevention of common digestive disorders 
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and unfavorable changes in the gut microflora, as seen in SIBO, is a relevant 
application.   
The aim of this study was to determine the effects of feeding a potential 
probiotic of canine origin, Lactobacillus reuteri X-18, on several biochemical 
analytes and immunological parameters in healthy beagle puppies.
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MATERIALS AND METHODS 
 
Source and Maintenance of Cultures 
Lactobacillus reuteri X-18 was isolated in a previous study done in the same 
laboratory as the current study.  The culture was obtained from the food 
microbiology culture collection at the Robert M. Kerr Food and Agricultural 
Products Center (FAPC) at Oklahoma State University.  It was subcultured weekly 
using a 1% inoculum into 10 mL of sterile Lactobacilli deMan Rogosa and Sharpe 
(MRS) broth (Difco Laboratories, Detroit, MI) and incubated at 37°C for 18 hours.  In 
between subcultures, the isolate was stored at 4°C and subcultured at least three 
consecutive times before use in the feeding trial. 
 
Milk Preparations 
A set of 100 mL aliquots of heat treated, 10% nonfat dry milk was prepared 
every three to four days and stored at 4° until use to feed the control group.  Frozen 
concentrated L. reuteri X-18 was prepared as described by Gilliland and Rich (1990) 
except that the culture was grown statically in 500 mL of sterile MRS broth for 18 
hours at 37°.  Concentrated cultures were stored in liquid nitrogen until needed.  
Frozen cultures used were prepared one week prior to the start of the feeding trial.  
The population of viable cells per vial was determined by pour plating serially 
diluted concentrated culture in 0.1% peptone (Difco Laboratories, Detroit, MI) with 
0.001% Antifoam A (Sigma-Aldrich, St. Louis, MO) using MRS agar.  Plates were 
incubated 48 hours at 37°C.  Based on the population, the appropriate number of 
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vials were thawed in cold water then added to the prepared milk to obtain a final 
population of 1.0 x 109 CFU/mL for the treatment group.  Frequency and storage of 
milk preparations for the treatment group were the same as the control group.  On 
both day 0 and day 3 of each set of milk preparations, confirmation of the dose of L. 
reuteri X-18 administered was done by pour plate method using MRS agar, with 
incubation at 37°C for 48 hours. 
 
Feeding Trial 
 From one group of ten female dogs and another group of ten male dogs, five 
2-month old beagle puppies of each sex were randomly allocated to one of two 
treatment groups.  Thus, each treatment group consisted of 5 female and 5 male 
puppies;  average body weights of each group were very similar.   Each puppy was 
individually housed in a separate run and allowed water ad libidum.  The puppies 
were cared for and handled in accordance with Oklahoma State University 
Institutional Animal Care and Use Committee guidelines.  All necessary vaccinations 
were administered during the 8-week period and the general overall well-being of 
the animals monitored by an in-house veterinarian.  The control group was fed only 
5-10 mL of 10% nonfat dry milk along with a measured dry dog food ration twice 
daily.  The treatment group was fed 5-10 mL of 10% nonfat dry milk containing 1.0 x 
109 CFU/mL L. reuteri X-18 along with a measured dry dog food ration twice daily.  
A day 0 baseline samples were obtained from each animal prior to administration of 






 At the conclusion of each week, body weights, blood samples, and fecal 
samples were collected.  Based on the recorded body weight of each animal, the 
following week’s dry food ration was calculated and pre-weighed for each 
individual.  After obtaining his or her body weight, each puppy was restrained to 
draw approximately 5 mL of blood from the jugular vein which was dispensed into 
individual blood collection vials to: 1) be analyzed by Antech Diagnostics (Irvine, 
CA) for a complete blood count and biochemical panel, and 2) be transported to 306 
FAPC where immunoglobulins would be analyzed.  Fecal samples were also 
collected at this time from the animal into sterile disposable centrifuge tubes (VWR, 
Suwanee, GA) and placed in ice in order to determine fecal immunoglobulin levels. 
 
Processing of Fecal Samples 
A portion of the fecal sample was used to make a fecal extract to determine 
fecal immunoglobulin levels.  The fecal extraction method was performed as 
described by Peters and others (2004).  The following immunoglobulins were 
measured:  IgA, IgG, IgE, and IgM.  An enzyme linked Immunosorbent assay (ELISA) 
quantitation kit for each canine immunoglobulin was used (Bethyl Laboratories, 
Inc., Montogomery, TX).  The appropriate dilutions were determined and assays 






Processing of Blood Samples 
Approximately 5 mL of blood was drawn from the jugular vein of each animal 
once every week for 8 weeks.  Aliquots of one mL were dispensed into appropriate 
tubes (tubes containing EDTA) designated by Antech Diagnostics to be used for a 
complete blood count and biochemical panel.  Blood samples were analyzed using 
an Olympus Model AU 5400 System (Center Valley, PA).  The biochemical panel 
tested for: aspartate aminotransferase (AST), alanine aminotransferase (ALT), total 
bilirubin, alkaline phosphatase, gamma glutamyl transferase (GGT), total protein, 
albumin, globulin, cholesterol, blood urea nitrogen (BUN), creatinine, phosphorous, 
calcium, glucose, amylase, lipase, sodium, potassium, chloride, creatine 
phosphokinase (CPK), triglycerides, and magnesium.  The remaining portion of 
blood was transferred to sterile red top vacutainers (BD vacutainer, Franklin Lakes, 
NJ) and placed in ice then at 4°C overnight.  The blood was centrifuged at 3,000 x g 
for 10 minutes to separate the serum.  The serum was then transferred to properly 
labeled cyrovials and stored at -20°C until analysis.  The blood serum was analyzed 
for IgA, IgG, IgE, and IgM.  An ELISA kit (Bethyl Laboratories, Inc., Montgomery, TX) 
for each canine immunoglobulin was used and analyses performed according to the 







 Serum and fecal immunoglobulin data along with the CBC and biochemistry 
panel data were analyzed using a repeated measures analysis of variance (ANOVA) 
using SAS v9.1 (SAS 2003).  The first-order autoregressive covariance structure was 
deemed appropriate.  The slice effect was used to test for any differences between 
treatments at various time points.  Differences were considered significant at the 
P<0.05 level.  Pair-wise differences were not needed to separate Least Squares 

















 Blood collection was carried out on a weekly basis over a period of eight 
weeks with the Day 0 collection time serving as the baseline since treatments were 
given following sample collection.  Results for serum immunoglobulins A, M, E, and 



















































































































































































































































































































































































































































































 While the overall serum IgA levels were not significantly different between 
the treatments (P=0.45), there was a significant difference between weeks 
(P=0.0004).  There was no significant treatment x week interaction (P=0.84).  
However, the treatment group produced lower levels of serum IgA for all sample 





Figure 1.  Comparison of serum IgA levels between the control group and the 


























 There were no significant differences between treatments (P=0.85), by week 
(P=0.13), or treatment x week interaction (P=0.50) for serum IgM.  The least square 





Figure 2.  Comparison of serum IgM levels between the control group and the 























The overall serum IgE levels were not significantly different between the 
treatments (P=0.20), and between weeks (P=0.06).  There was no significant 
treatment x week interaction (P=0.36).  Although not significant, the treatment 
group showed levels of serum IgE to be lower than the control group until week 8, 
while the control group experiences a decrease in levels starting at week 4 and 





Figure 3.  Comparison of serum IgE levels between the control group and the 

























 The overall serum IgG levels were not significantly different between the 
treatments (P=0.65) but there was a significant difference between weeks (P=0.03).  
There was no significant treatment x week interaction (P=0.91).  The least squared 





Figure 4.  Comparison of serum IgG levels between the control group and the 


























 Results for fecal immunoglobulins A, M, and G are given in Table 3.  Fecal IgA 
had a significant week effect (P=0.03) with no significant treatment (P=0.29) or 
treatment x week (P=0.24) effect (Figure A1 Appendix A).  Fecal IgM had a 
significant week effect (P=0.01) with no significant treatment (P=0.73) or treatment 
x week (P=0.68) effect (Figure A3 Appendix A).  Fecal IgG had a significant week 
effect (P=0.02) with no significant treatment (P=0.90) or treatment x week (P=0.80) 
effect (Figure A2 Appendix A).  Fecal IgE levels were not within the detectable range 
of the ELISA quantitation kits used.   
 
Complete Blood Count 
 The complete blood count results are found in Table 4.  Significant treatment 
effects could be seen for red blood cells (P=0.0247), mean cell volume (P=0.0056), 
mean cell hemoglobin concentration (P=0.0411), eosinophils (P=0.0355), and 
basophils (P=0.0500).  Significant week effects could be seen in all measurements 
except for neutrophils (P=0.1733), eosinophils (P=0.3921), and basophils 






















































































































































































































































































































































































































































































































































































































































































































































 Although no significant differences could be seen in treatment x week effects, 
the following observations were made from the data collected.  The numbers of 
white blood cells were lower in the treatment group than the control group except 
for a slight spike during week 6 (Figure 5).  The red blood cell counts were higher in 
the treatment group than the control group throughout the feeding trial (Figure 6).  
Levels of hemoglobin for the treatment group were higher than the control group 
except during week 4 where they were slightly lower (Figure 7).  Mean cell volume 
(MCV) had a treatment (P=0.0056) and week effect (P<0.0001) and the MCV of the 
treatment group was lower than the control throughout the feeding trial (Figure 
12).  Lymphocyte counts for the treatment group were higher than those of the 
control group with the exception of week 5, where they were only slightly lower 
(Figure 8).  Basophil counts were higher in the treatment group than the control 
group for the duration of the trial except for week 7 (Figure 9). Platelet counts for 
the treatment group were lower than the control group except for day 0 and week 8 
(Figure 10).  Eosinophil levels were consistently lower in the treatment group 
throughout the feeding trial (Figure 11).  There were significant differences 
between control and treatment groups during various weeks.  During week 1, the 
RBC and hematocrit levels in the treatment group were significantly higher in the 
treatment groups.  During week 3, RBC levels were significantly higher in the 
treatment group than the control group.  During week 4, the lymphocyte level was 
significantly higher in the treatment than the control group where as the neutrophil 
and monocyte levels in the treatment group were significantly lower than the 
control group.  For week 5, the treatment group had significantly lower levels of 
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MCV than the control group and the treatment group had significantly higher levels 
of MCHC than the control group.  During week 7, the same could be seen for MCV 
and MCHC.  During week 8, the MCV levels were significantly higher in the treatment 
than control group. 
Additional complete blood count parameters that were not statistically 
different between groups are in Figures C1 to C5 in Appendix C.  Reference values 





Figure 5.  Comparison of white blood cell counts between the control group and the 
































Figure 6.  Comparison of red blood cell counts between the control group and the 
treatment group over a period of 8 weeks; a,bSuperscripts between trts on the same day 





































Figure 7.  Comparison of levels of hemoglobin between the control group and the 

































Figure 8.  Comparison of lymphocyte counts between the control group and the 
treatment group over a period of 8 weeks; a,bSuperscripts between trts on the same day 





























Figure 9.  Comparison of basophil counts between the control group and the 




























Figure 10.  Comparison of platelet counts between the control group and the 






































Figure 11.  Comparison of eosinophil counts between the control group and the 







































Figure 12.  Comparison of mean cell volumes between the control group and the 
treatment group over a period of 8 weeks. a,bSuperscripts between trts on the same day 




































Blood Chemistry Panel 
 Overall statistical results for the blood chemistry panel are included in Table 
5.  All tested analytes showed a week effect (P<0.05).  Calcium significantly differed 
by treatments (P=0.0180) and by week (P<0.0001) but not with a treatment x week 
effect (P=0.48).  Calcium levels were higher in the treatment group than the control 
group except for weeks 6 and 7 (Figure 11).  During weeks 1 and 3, calcium levels of 
the treatment group were significantly higher than the control groups (P=0.0210 
and P=0.0370, respectively).   
Total protein values showed significant difference between treatments 
(P=0.0207) and between weeks (P<0.0001) but not a significant treatment x week 
effect (P=0.0803).  Throughout the feeding trial, the treatment group had higher 
total protein levels than the control group.  During weeks 1, 3, and 7, total protein 
values were significantly higher in the treatment group than the control group 
(P=0.0025, P=0.0329, and P=0.0397, respectively) (Figure 13).   
Aspartate aminotransferase (AST) showed a treatment effect (P=0.0183) and 
week effect (P<0.0001) but no treatment x week effect was observed (P=0.7852) 
(Figure 14).  For the duration of the study, the treatment group had higher levels of 
AST than the control group.  During week 1, AST values were significantly higher in 
the treatment group than the control group (P=0.0110). 
Gamma glutamyl transferase (GGT) displayed significant treatment 
(P=0.0211), week (P<0.0001), and treatment x week (P=0.0196) effects (Figure 15).  
Values were generally higher in the treatment group than the control with the 
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exceptions of week 1 and week 8.  GGT values were significantly higher in the 
treatment group than the control group during week 2 (P<0.0001) (Figure 15). 
Week and treatment x week effects were observed with creatinine levels 
(P<0.0001 and P=0.0047, respectively).  Significant differences could be seen 
between treatments on day 0 and week 1 (P=0.0114 and P<0.0001, respectively) 
(Figure 16). 
Blood chemistry panel analytes that were not statistically different between 
treatments are in Figures B1 to B18 in Appendix B.  Reference values for the canine 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 13. Comparison of levels of calcium between the control group and treatment 
group over the period of eight weeks;  a,bSuperscripts between trts on the same day 






























Figure 14.  Comparison of levels of total protein between the control group and 
treatment group over the period of eight weeks; 
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Figure 15.  Comparison of levels of AST between the control group and treatment 
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 (P<0.05) 








Figure 16.  Comparison of levels of GGT between the control group and treatment 
group over the period of eight weeks; 




























 a,bSuperscripts between trts on the same day 
 








Figure 17.  Comparison of levels of creatinine between the control group and 
treatment group over the period of eight weeks; 
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 The dogs were randomly allocated to each treatment group based on body 
weight and sex (Table 6).  The overall statistical results of body weights are included 
in Table 5.  While there was no treatment (P=0.88) or treatment x week (P=0.82) 
effect, there was a significant difference by week (P<0.0001).  Although not 
significantly different, the body weights of the treatment group were slightly higher 
than the control group except for week 8 (Figure 17 and Table 7).  
76 
 























1All treatments were fed 5 -10mL twice a day; Lactobacilli 
concentrations fed were ~1.0 x 10
9
 CFU/mL




L. reuteri  X-18 (n=10)







































































































































































Figure 18.  Comparison of body weights between the control group and treatment 



























































































































































































































































































































































































































































































































































































































































































































































































































































 Immunoglobulins are gamma globulin proteins that are used by the immune 
system to identify and neutralize foreign particles such as bacteria or viruses.  They 
are produced by plasma B cells.  There are five kinds of antibodies grouped into 
different isotypes, IgG, IgA, IgM, and IgE usually observed in dogs.  The antibody 
isotype of a B cell changes during cell development and activation.  Immature B 
cells, which have never been exposed to an antigen, are known as naïve B cells and 
express only the IgM isotype in a cell surface bound form.  B cells begin to express 
IgM when they reach maturity and are ready to react to antigens.  After a response 
to an antigen, the cell divides and differentiates into an antibody producing cell 
called a plasma cell.  In this stage, the B cell starts to produce antibody in a secreted 
form rather than a membrane-bound form.  Some daughter cells of the activated B 
cells undergo isotype switching which causes the production of antibodies to change 
from IgM to the other isotypes, IgA, IgG, or IgE, which all have defined roles in the 
immune system.  The measurement of serum immunoglobulin concentrations is one 
of the most commonly used methods of assessing immune competence in dogs.   
Immunoglobulin G (IgG) is the major immunoglobulin produced by plasma 
cells (~70-75% of total immunoglobulins).  It is the only antibody capable of 
crossing the placenta to give passive immunity.  IgG is involved in secondary 
antibody response and is activated by proinflammatory cytokines.  The mode 
protection against microorganisms is by agglutination, complement fixation, 
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opsonization, and neutralization (Burtis and others 2006).  In this study, there was 
no significant difference between the control and treatment group.  However, the 
mean concentration of serum IgG in the treatment group was higher than that of the 
control group with the value of the correlation coefficient being 0.75.  We can 
deduce from this value that both groups had similar trends.  Interestingly, both 
groups had elevated serum IgG concentrations compared to published reference 
values of 3.0 x 106 – 6.0 x 106 ng/mL  (Loeb 1999).  This could be due to the fact that 
the parasitic infections that occurred prior to the feeding trial could have caused 
increases in IgG.  While treatments clear feces of oocysts and classify animals as 
healthy, it is known that such infections can take months for the animals to produce 
enough antibodies to completely clear the parasite naturally. 
Immunoglobulin A makes up 10-15% of total immunoglobulins.  It is 
synthesized mainly by plasma cells in the mucous membranes of the gut, respiratory 
tract, and urogenital tract and can also be found in saliva and, tears, and breast milk.  
The mode of action of IgA is to prevent colonization by pathogens and initiate 
inflammatory reactions (Burtis and others 2006).  One might expect that the 
probiotic treatment would enhance concentrations of IgA.  However, there was no 
significant difference between the groups with concentrations of IgA in the 
treatment group being slightly lower than those in the control group.  Similarly to 
serum IgG, the value of the correlation coefficient was 0.95 indicating a very strong 
correlation to each other.  Compared to the reference value, 8.0 x 105 ng/mL (Loeb 
1999), concentrations of serum IgA in this study were found to be slightly lower.   
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Immunoglobulin M (IgM) plays the role of complement activator and makes 
up 5-10% of total immunoglobulins.  The role this immunoglobulin plays is in 
eliminating pathogens in the early stages of humoral immunity before there is 
sufficient IgG therefore appearing early in the course of an infection (Burtis and 
others 2006).  There was not a significant difference in IgM concentrations between 
the two groups with the mean of the concentrations being the same for both groups.  
In comparison to the reference value of 1.5 x 106 ng/mL (Loeb 1999), the 
concentration of both groups were slightly higher.  As in the case of IgG, the natural 
clearing of the parasite by innate antibodies can take several months.  This elevated 
level of IgM correlates to the elevated IgG concentrations also observed. 
Immunoglobulin E (IgE) is usually found in trace amounts since it tightly 
binds to mast cells.  Allergens bind IgE, stimulating mast cells to release histamine, 
cytokines, and other inflammatory mediators.  IgE has also been shown to protect 
against parasites (Burtis and others 2006).  No significant difference was seen 
between the groups.  To aid in decreasing hypersensitivity to allergens, one would 
expect enhanced concentrations of serum IgE by ingesting a probiotic culture.  
Unfortunately, levels of serum IgE in the treatment group were found to be slightly 
lower than those in the control group.   
Only significant week effects could be seen when comparing fecal 
immunoglobulin concentrations of both control and treatment groups.  Extremely 
high levels of variation were expected (Loeb 1999) and data collected supported 
this.  It has been the center of much debate on whether or not fecal immunoglobulin 
concentrations are an accurate depiction of the immune system.  As seen in previous 
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studies and the current study, variability in concentrations render these results 
inconsequential.   
In a similar study using Lactobacillus acidophilus, the findings showed an 
increase in serum IgG (Baillon and others 2004) and the findings in this study are 
comparable.   
 
Complete Blood Count and Blood Chemistry Panel 
 The standard research dog is the beagle.  Their disposition, temperament, 
and size make this breed a suitable choice for scientific studies.  Stress alters the 
results of various clinical chemistry determinations so the most uniform data is 
obtained by acclimating the dogs, housing them in a stress-free environment, and 
handling them gently but firmly when drawing blood samples (Loeb 1999).   
 The complete blood count (CBC) is a profile of tests used to describe the 
quantity and quality of the cellular components in blood and some substances in 
plasma.  The CBC should be evaluated systematically and results outside reference 
values for that species are usually considered abnormal.  However, reference values 
are often not optimal since they are derived from limited numbers of adult animals 
not segregated by age, sex, or breed (Willard and Tvedten 2004).  Prominent age-
related changes occur in dogs.  At birth, red blood cells (RBCs) are very large with a 
mean corpuscular volume (MCV) about 95 fl.  The MCV decreases to adult values by 
2 to 3 months of age.  At 5 to 6 weeks of age, puppies normally have a packed cell 
volume (PCV) or hematocrit % around 30%, and total protein around 5.3 g/dL.  
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These values could be confused with anemia if compared with adult reference 
ranges (Willard and Tvedten 2004).   
 A complete CBC was evaluated for each dog in this study from blood 
collections done weekly throughout the duration of the feeding trial.    Following are 
the conclusions that were made based on those results. 
 White blood cells (WBC) or leukocytes are the cells of the immune system.  
They can be divided into two major groups:  1) Granulocytes and 2) Agranulocytes.  
Granulocytes have membrane-bound enzymes that aid in endocytosis.  Cells 
included in this group are neutrophils, basophils, and eosinophils.  Agranulocytes, 
contrary to their name have granules which are lysosomes.  Cells included in this 
group are lymphocytes and monocytes.  Neutrophils are the frontline attack cell in 
acute inflammation and the most abundant leukocyte.  They phagocytize and kill 
microorganisms and can release antibacterial substances such as defensin and 
lysozyme (Gaunt 2004).  Basophils have receptors for IgE and augments 
hypersensitivity reactions to allergens, leading to vascular permeability, induction 
of bronchoconstriction, and inhibition of coagulation.  Basophils are present in 
relatively low numbers in dogs (Gaunt 2004).  Eosinophils initiate the inflammation 
response and can suppress immediate-type hypersensitivity.  If eosinophils are 
present in high numbers, cytotoxic mediators can injure host tissues.  Therefore, 
they are usually present in very low numbers (Gaunt 2004).  Monocytes develop 
into macrophages which have immunoglobulin and complement receptors to help 
enhance phagocytosis.  They essentially function as antigen-presenting cells (APC) 
for humoral and cell-mediated immune responses (Gaunt 2004).  Lymphocytes are 
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involved in immune function.  Lymphocytes consist of B lymphocytes and plasma 
cells that produce antibody to specific antigens, providing a humoral response, and 
T lymphocytes that are involved in immunoregulation of antibody-mediated and 
cell-mediated immune responses.  Lymphocytes are the second most abundant 
leukocyte (Gaunt 2004). 
 Red blood cells (RBC) or erythrocytes are the principal transporters of 
oxygen to from lungs to body tissues and carbon dioxide in the opposite direction.  
RBC’s transport function is possible through the use of the iron-containing molecule, 
hemoglobin, present in the cell’s cytoplasm (Meuten and Thrall 2002).  In a CBC, 
erythrocytes are evaluated by looking at a panel of test parameters.  This panel 
consisted of hemoglobin concentration, % hematocrit or packed cell volume (PCV), 
mean cell volume (MCV), mean corpuscular hemoglobin (MCH), mean cell 
hemoglobin concentration (MCHC), and platelets.  Hematocrit determines the 
proportion of blood volume occupied by RBCs, MCV is the average volume of a RBC, 
MCH is the amount of hemoglobin, by weight, in the average RBC, MCHC is the 
concentration of hemoglobin in the average RBC, and platelets function in 
hemostasis (Meuten and Thrall 2002).  The results of the CBC done in this study 
showed that all measurements were, except for platelets and eosinophils , within 
the reference range determined in-house by Antech Diagnostics in Irvine, CA.  Both 
control and treatment groups showed elevated levels of platelets and eosinophils 
compared to their respective reference ranges.  However, the values were not so 
extreme to cause alarm especially knowing that reference ranges are not optimal 
values due to variations in breed, age, and sex.  To note, when comparing least 
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square means of these “abnormal” measurements, the treatment groups had lower 
numbers of eosinophils and platelets compared to the control groups.  
 Studies on the effect of age on numerous clinical chemistry and hematology 
parameters in healthy dogs have found that even when statistically significant, the 
changes tended to be fairly small.  Albumin and serum iron decreased with age, 
while potassium, globulin, and total protein increased.  Age-related increases in GGT 
and amylase were also observed (Lowseth and others 1990; Strasser and others 
1993; Vajdovich and others 1997).  In this study, the following conclusions could be 
made. 
 When focusing on the least square means of both the control and treatment 
groups, all values were within the reference range and considered normal.  
However, there were three exceptions.  Phosphorous and alkaline phosphatase 
levels of both the control and treatment groups were elevated compared to the 
reference values while triglyceride levels of both the control and treatment groups 
were below the reference range.   The elevated phosphorous and alkaline 
phosphatase levels are not necessarily abnormal since this is commonly seen in 
young, growing animals.  As in the case with similar results seen in the CBC, these 
values are not extreme enough to cause concern and the animals would still be 
considered healthy rather than diseased.  Interestingly, significant differences 
between the control group and treatment group could be seen during various 
weeks.  On day 0, creatinine levels in the treatment group were significantly lower 
than the control group.  On the same day, magnesium levels in the treatment group 
were significantly higher than the control group.  During week 1, the treatment 
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groups were significantly higher than the control group for the following analytes:  
AST, total protein, albumin, creatinine, calcium, and potassium.  During week 2, 
levels of GGT in the treatment group were significantly higher than those in the 
control group.  During week 3, levels of total protein, albulmin, and calcium were 
significantly higher in the treatment group than the control group.  During week 7, 
levels of globulin were significantly higher in the treatment group than those in the 
control group. 
Overall, no significant differences could be seen between the control and 
treatment groups with respect to immunoglobulins.  For the CBC, the least square 
means of both the control and treatment groups were within the reference range 
with only two parameters (eosinophils and platelets) being slightly elevated.  Those 
elevated values could be due to typical variations as a result of the testing profiles 
that were used to determine the reference ranges (sex, breed, and age).  Based on 
these results, the animals were still considered healthy with no extreme effects seen.  
For the biochemistry panel, only GGT and creatinine show a significant treatment x 
week effect.  The least square means of both the control and treatment groups were 
within the reference range, which are consistent with the healthy status of the dogs.   
Possible confounding factors 
There were a number of factors observed during the course of the study 
apart from the probiotic treatment that may have contributed to the results 
observed.  These included routine vaccinations, parasitic infections, dehydration, 





Vaccinations work by presenting a foreign antigen to the immune system in 
order to evoke an immune response, essentially an artificially induced immune 
response.  Vaccines are classified as live (attenuated) or killed (inactivated).  As in 
Jenner’s discovery of the smallpox vaccine, a live vaccine stimulates immunity via a 
transient infection produced by a live, replicating organism (Jenner 1798).  
Inactivated vaccines consist of killed organisms or non-replicating sub-cellular 
components that stimulate a lower level and shorter duration of immunity that that 
of live vaccines.  Therefore, adjuvants are used in combination with killed vaccines 
to enhance antibody response (Kwak and Longo 1996).  Adjuvants can stimulate 
innate immunity or adaptive immunity.  Innate immunity adjuvants such as 
lipopolysaccharide (LPS), bind antigen-presenting cells to produce inflammatory 
cytokines and activate adaptive immunity while adaptive immunity adjuvants such 
as cytokines, bind and activate highly specific receptors on T cells (Marciani 2003).   
The widespread use of vaccines in dogs became possible with the development and 
commercial availability of egg-adapted and tissue culture-derived modified live 
distemper and adenovirus vaccines (Piercy 1961).   As vaccination became 
widespread and less clinical disease occurred among domestic dogs, it was 
suggested that the natural re-exposure of vaccinated dogs would decrease, leading 
to a reduction in natural boosting.  It was believed that this natural boosting was 
necessary for the maintenance of long-term population immunity (Piercy 1961) and, 
as a result, recommendations were made for vaccines to be administered annually.  
Since the 1960s, the annual vaccination of animals has become established as a 
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standard of practice and has reduced the incidence of some diseases (McCaw and 
others 1998).   Vaccines can be grouped into 3 categories.  Core vaccines include 
those against canine distemper, canine parvovirus (cpv), canine adenovirus (cAV),  
and rabies virus.  Non-core vaccines are those against parainfluenza 
virus, Bordetella species, and Leptospira species.  Vaccines against Borrelia species 
and coronavirus are considered non-core or not recommended, depending on the 
source (Schultz 1998).  The time vaccinations are administered range from 5 weeks 
to twelve and fifteen weeks of age (AMVA 2002).  According to records of the 




 The vaccinations were administered before delivery of the animals to OSU 
Veterinary Medicine/Animal Resources with the last vaccination, given at OSU, one 
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major goal of the trial was to study immune effects of dogs upon ingestion of a 
probiotic.  Because of the immunostimulatory effects vaccinations confer, 
vaccinations administered during the feeding trial would alter immune parameters, 
preventing one from differentiating between the effects of the probiotic with the 
effects of the vaccine.   
Parasitic Infections 
 Giardia has a broad host range, although the adverse consequences of 
Giardia infection and its pathogenic potential are best recognized in humans.  Its 
simple life cycle provides ample opportunities for the parasite to be transmitted 
directly from one infected individual to another, or indirectly through 
contamination of the environment or food. In this respect, water is an important 
vehicle for the transmission of Giardia.  The pathogenesis of Giardia has not been 
elucidated and symptoms, which include acute or chronic diarrhea, dehydration, 
abdominal pain and weight loss, are highly variable (Thompson and others 1993), 
and may not be evident in a significant proportion of infected individuals 
(Rodriguez-Hernandez and others 1996).  Pathophysiological processes upon 
infection include altered, increased epithelial permeability that results in an 
inflammatory response and both digestive and absorptive changes (Scott and others 
2002).  Giardia also induces apoptosis that correlates with the loss of epithelial 
barrier function and the subsequent increase in permeability (Chin and others 
2002).  However, apoptosis and the severity of disease are determined by strain-
dependent virulence factors of the parasite, as well as by the developmental, 
nutritional, and immunological status of the host (Chin and others 2002; Scott and 
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others 2002).  Increased intestinal permeability may result in the uptake of luminal 
antigens which may exacerbate the occurrence of allergic disorders, a complication 
often reported in humans infected with Giardia (Scott and others 2002) and a factor 
that may confound the etiology of nutritional disorders.  Of particular note in 
reference to the possible increase in allergic disorders, the levels of eosinophils 
found in this study were elevated.  As you may recall, eosinophils are the immune 
cells responsible for allergic, hypersensitivity reactions.  This increase could 
possibly be related to the concurrent parasitic infection.  Although Giardia is 
common in dogs, it is rarely associated with clinical disease in these animals. 
However, if clinical giardiasis is reported, it is usually associated with kennel 
situations where the effects of overcrowding may cause stress and exacerbate the 
effects of an infection (Robertson and others 2000).  Infections with Giardia 
stimulate humoral immunity that results in a self-limiting infection in many animal 
species (Olson and others 2000). Unfortunately, it may take several months for the 
host to produce protective antibodies that can eliminate the parasite.  Treatment of 
Giardia-infected dogs is usually recommended whether or not they are clinically ill 
because of the perceived potential for zoonotic transmission and treatment 
generally consists of oral suspensions of benzimidazoles. 
 Isospora species are protozoan parasites that are members of the group of 
organisms referred to as coccidia.  Coccidia are identified based on the structure of 
their sporulated oocyst stage. The oocyst stage is an environmentally resistant stage 
which is excreted in the host feces (Lindsay and others 1997).  The presence of 
oocysts in the feces is not always indicative of clinical infection (Lindsay and 
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Blagburn 1991).  Isospora species can cause serious disease in humans and nursing 
pigs. However, in dogs, clinical disease is seldom seen (Lindsay and others 1997).  
The diagnosis of coccidiosis in animals is based on clinical signs such as diarrhea, 
history, evaluation for potential co-pathogens, and demonstration of coccidial 
oocysts of a pathogenic species in the animal’s feces (Lindsay and others 1997).  
Isospora develops in cells in the lamina propria of the posterior small intestine and 
it has been suggested that the stress of weaning and shipping may enhance Isospora 
infections (Lepp and Todd 1974).  The significance of diarrhea caused by coccidia in 
dogs is unclear therefore the treatment of the condition is also unclear.  Suspected 
clinical cases can be treated with a variety of drugs used alone or in combination.  
Sulfadimethoxine given at 50 mg/kg orally once a day for 10 to 14 days will 
eliminate oocyst excretion in most dogs (Lindsay and Blagburn 1995) or the 
combination of ormetoprim (11 mg/kg) and sulfadimethoxine (55 mg/kg) given 
orally for up to 23 days has also been effective in dogs (Dunbar and Foreyt 1985).  
 During the week following delivery of the beagles to OSU Veterinary 
Medicine/Animal Resources, blood and mucous was observed in the feces of almost 
all dogs.  Upon testing, it was determined that 7of the control dogs tested positive 
for Giardia and 3 for Isospora.  Of the treatment group, 9 tested positive for Giardia 
and 3 for Isospora.  Infected animals were treated with oral suspensions of Panacur© 
(fenbendazole) for giardiasis and Albon© (sulfadimethoxine) for coccidiosis 
according to the manufacturer’s recommended doses.  A follow-up diagnosis was 
made 2 ½ weeks later with both control and treatment dogs testing negative for 
Giardia but 4 control dogs were positive for Isospora as well as 5 treatment dogs.  
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Treatments were administered as deemed appropriate.  The week following 
diagnosis and treatment, the feeding trial began with no other documented cases of 
either giardiasis or coccidiosis occurring during the trial.   
Dehydration 
 Dehydration indicates lack of water and fluids that the body needs to 
maintain normal functions.  Dehydration could be a result of loss of fluids due to 
vomiting, diarrhea, and fever or the lack of fluid intake due to nausea, loss of 
appetite, or inaccessibility.  Tests such as blood chemistry (specifically electrolytes), 
complete blood count, BUN, and creatinine are useful indicators of dehydration.  
Elevated electrolytes, red blood cells, hematocrit, and elevated BUN and creatinine 
levels could be the result of dehydration (Dugdale 2008).  Elevated levels of the 
following analytes included in a CBC and blood chemistry panel are generally 
considered indicative of dehydration: 














 As mentioned in the previous section, the dogs used in this study had 
experienced bouts of diarrhea, presumably, due to parasitic infections and stress 
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prior to the start of the feeding trial.  In addition, individual animals were housed in 
separate runs with the water supply being freely available to each animal by a 
pressure trigger spout mechanism.  This mechanism opens a valve releasing water 
upon the biting or tongue pressure of the animal.  Once the animals were placed in 
individual runs, it was observed that some animals had difficulty utilizing this 
mechanism.  The combination of infection, stress, and inaccessibility to water could 
have resulted in the animals suffering from mild dehydration.   The overall results of 
the CBC we normal and within the published reference ranges and did not indicate 
that dehydration was an issue.  In reference to blood chemistry, all analytes but two 
were also normal.  Elevated levels of alkaline phosphatase could be contributed to 
skeletal growth and not dehydration.  Elevated levels of phosphorous, as seen in our 
findings, are usually inversely related to calcium levels or seen in combination with 
elevated BUN and creatinine levels (Loeb 1999).  However, calcium, BUN and 
creatinine levels were normal.  Therefore, this phenomenon cannot be explained.  
Lowered triglycerides can not be the result of dehydration but possibly due to the 
effects of the probiotic (Taylor and Williams 1998) 
Nictitans Gland Prolapse 
Nictitans gland prolapse, otherwise known as cherry eye, is the prolapsed of 
the tear gland of the third eyelid.  It is the result of weakened connective tissue that 
attaches the gland to the surrounding structures of the eye. This weakness of the 
connective tissue allows the gland to prolapse.  Once the gland prolapses and is 
exposed to air and irritants and can become infected and/or begin to swell.  The 
gland often becomes irritated, red, and swollen.  A number of breeds of dogs are 
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pre-disposed to having this condition with beagles being one of them (Turner 2008).  
One dog from the treatment group and one from the control group were diagnosed 
with this condition midway through the trial.  Inflammation and stress from cherry 




 Consumption of the probiotic was not associated with any significant 
changes in the clinical status of the dogs as determined by the use of a standard 
physical examination, CBC, and biochemical profiles.  Since healthy animals were 
used, one would not expect to see any differences between the treatment groups.  
The lack of differences could be considered advantageous, as there were no adverse 
side effects observed due to the consumption of the probiotic. 
Future Research 
 A lipopolysaccharide (LPS) challenge done in a similar manner as those 
previously done in other animal and human trials (Gallay and others 1993; 
Altenburg and others 2002) would be a possible research project for the future that 
could allow one to discern differences expected between the control group and 
those ingesting the probiotic.  The primary role of the immune system is to detect 
and recognize foreign invaders.  Bacteria have developed mechanisms to promote 
their adhesion onto host cells and colonization.  On the other hand, the host cells 
have developed mechanisms to detect bacterial cell surface components to promote 
phagocytosis and killing of the microorganisms.  The concept of innate immunity is 
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derived from pattern-recognition systems which make innate immunity very 
specific, allowing differentiation between host and pathogens (Heumann and Roger 
2002).  The molecules and pathways involved in the recognition of LPS by the 
immune system have been studied quite extensively.  The use of LPS allows 
scientists to simulate an infection resulting in a typical immune response one would 
see if actually dosed with a pathogen without actually having to handle the 
pathogenic microorganism.  The use of challenged animals may accentuate 
differences in the tested parameters proving the efficacy of using probiotics in 
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Figure A1.  Comparison of fecal IgA levels between the control group and the 
























Figure A2.  Comparison of fecal IgG levels between the control group and the 



























Figure A3.  Comparison of fecal IgM levels between the control group and the 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure B1.  Comparison of ALT between the control group and the treatment group over a 

























Figure B2.  Comparison of total bilirubin between the control group and the treatment 


































Figure B3.  Comparison of levels of alkaline phosphatase between the control group and the 

































Figure B4.  Comparison of levels of albumin between the control group and the treatment 
























a,bSuperscripts between trts on the same day are 









Figure B5.  Comparison of levels of globulin between the control group and the treatment 




























Figure B6.  Comparison of levels of BUN between the control group and the treatment group 


























Figure B7.  Comparison of levels of amylase between the control group and the treatment 

























Figure B8.  Comparison of levels of lipase between the control group and the treatment 























Figure B9.  Comparison of sodium levels between the control group and the treatment 





























Figure B10.  Comparison of potassium levels between the control group and the treatment 































Figure B11.  Comparison of magnesium levels between the control group and the treatment 































Figure B12.  Comparison of cholesterol levels between the control group and the treatment 






























Figure B13.  Comparison of glucose levels between the control group and the treatment 
























Figure B14.  Comparison of chloride levels between the control group and the treatment 






























Figure B15.  Comparison of levels of creatine phosphokinase between the control group and 






















Figure B16.  Comparison of levels of triglycerides between the control group and the 
























Figure B17.  Comparison of levels of triglycerides between the control group and the 




























































BUN - Blood Urea Nitrogen
6
CPK - Creatine Phosphokinase
Table XB1.  Blood Chemistry Panel
a
a
Performed using an Olympus Model AU 5400 System   (ANTECH Diagnostics, Irvine, CA)
1
AST - Aspartate Aminotransferase
2
ALT - Alanine Aminotransferase
3
AlkPhos - Alkaline Phosphatase
4
GGT - Gamma Glutamyl Transferase
b





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure C1.  Comparison of MCH between the control group and the treatment group over a 



























Figure C2.  Comparison of MCHC between the control group and the treatment group over a 
































Figure C3.  Comparison of neutrophils between the control group and the treatment group 






























Figure C4.  Comparison of monocyte counts between the control group and the treatment 





























Figure C5.  Comparison of levels of hematocrit between the control group and the treatment 



























Analytes Tested Reference Values
b Units
White Blood Cell (WBC) 4.0-15.5 10
3
/µL
Red Blood Cell (RBC) 4.8-9.3 10
6
/µL
Hemaglobin (HGB) 12.1-20.3 g/dL
Hematocrit (HCT) 36-60 %












Platelet Count 170-400 10
3
/µL
Table C1.  Complete Blood Count
a
b
Reference values established in-house using clinically normal dogs of all breeds 
and ages
a
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Scope and Method of Study:   The main objective of the present study was to see the 
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Findings and Conclusions: Overall, no significant differences could be seen between 
the control and treatment groups with respect to immunoglobulins.  For the 
CBC, the least square means of both the control and treatment groups were 
within the reference range with only two parameters (eosinophils and 
platelets) being slightly elevated.  Those elevated values could be due to 
variations as a result of the testing profiles that were used to determine the 
reference ranges (sex, breed, and age).  Based on these results, the animals 
were still considered healthy with no extreme effects seen.  For the 
biochemistry panel, only GGT and creatinine showed a significant treatment 
x week effect.  The least square means of both the control and treatment 
groups were within the reference range, which are consistent with the 
healthy status of the dogs.  Consumption of the probiotic was not associated 
with any significant changes in the clinical status as determined by the use of 
a standard physical examination, CBC, biochemical profiles, and 
immunoglobulin concentrations.  The lack of differences could be considered 
advantageous, as there were no adverse side effects observed due to the 
consumption of the probiotic. 
